Overview

A Study of ONO-1110 in Patients With Major Depressive Disorder

Status:
RECRUITING
Trial end date:
2026-08-31
Target enrollment:
Participant gender:
Summary
To Evaluate the Efficacy and Safety of ONO-1110 in Patients with Major Depressive Disorder
Phase:
PHASE2
Details
Lead Sponsor:
Ono Pharmaceutical Co. Ltd